Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the entities listed below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.001 par value, of KalVista Pharmaceuticals, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing.
Vivo Ventures VI, LLC | ||
September 12, 2018 | ||
(Date) | ||
/s/ Albert Cha | ||
(Signature) | ||
Managing Member | ||
(Title) | ||
Vivo Opportunity, LLC | ||
September 12, 2018 | ||
(Date) | ||
/s/ Albert Cha | ||
(Signature) | ||
Managing Member | ||
(Title) | ||
Vivo Capital IX, LLC | ||
September 12, 2018 | ||
(Date) | ||
/s/ Albert Cha | ||
(Signature) | ||
Managing Member | ||
(Title) |